Anthera Pharmaceuticals Inc. buy Maxi_Scalibusa
Start price
23.02.18
/
50%
€2.16
Target price
15.03.18
€3.61
Performance (%)
-81.38%
End price
15.03.18
€0.40
Summary
This prediction ended on 15.03.18 with a price of €0.40. The BUY prediction by Maxi_Scalibusa for Anthera Pharmaceuticals Inc. performed very badly with a performance of -81.38%. Maxi_Scalibusa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Anthera Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by Maxi_Scalibusa for this prediction
In the thread Anthera Pharmaceuticals Inc. diskutieren
Maxi-Scalibusa stimmt der Buy-Einschätzung von stratec zu
Maxi-Scalibusa stimmt am 22.02.2018 der Buy-Einschätzung von stratec mit dem Kursziel 4$ zu.
Überschrift: Anthera Pharmaceuticals initiated with Buy rating and $10 (492% upside) price target at ROTH Capital.
(Vom Mitglied beendet)